Joint (JYNT) EBITDA Margin (2013 - 2026)

Joint (JYNT) posted EBITDA Margin of 5.9% for Q1 2026, up 20.43% sequentially from 4.89% in Q4 2025, and up 1108.0% YoY from 0.49% in Q1 2025.

Analysis

Joint (JYNT) EBITDA Margin (2013 - 2026) Analysis & Trends

Joint has reported EBITDA Margin for 14 years, with the latest figure at 5.9% in Q1 2026.

Quarterly EBITDA Margin rose 1108.0% year-over-year to 5.9% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.13% (up 516.0% YoY) and the FY2025 annual result came in at 1.66%, up 196.0% from the prior year.
EBITDA Margin grew to 5.9% in Q1 2026 per JYNT's latest filing, from 4.89% in the prior quarter.
Over five years, EBITDA Margin peaked at 7.83% in Q4 2023 and troughed at 14.11% in Q2 2024.
A 5-year average of 0.75% and a median of 0.17% in 2022 frame the typical range for EBITDA Margin.
The sharpest annual moves came in 2022 and 2026: EBITDA Margin sank 1817 bps in 2022, then soared 1108 bps in 2026.
Over 5 years, EBITDA Margin stood at 5.85% in 2022, then jumped by 34 bps to 7.83% in 2023, then slipped by 30 bps to 5.5% in 2024, then fell by 11 bps to 4.89% in 2025, then rose by 20 bps to 5.9% in 2026.
According to Business Quant data, EBITDA Margin over the past three periods registered 5.9%, 4.89%, and 1.2% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBITDA Margin (Qtr)
1	HCA Healthcare	90.36 Bn	89.35 Bn	15.19 Bn	-12.60%
2	Tenet Healthcare	22.02 Bn	19.85 Bn	4.45 Bn	26.67%
3	Encompass Health	12.13 Bn	11.99 Bn	1.34 Bn	2.10%
4	Davita	11.78 Bn	11.09 Bn	1.16 Bn	16.29%
5	Universal Health Services	10.09 Bn	9.95 Bn	3.29 Bn	11.14%
6	Ensign	9.97 Bn	9.65 Bn	306.24 Mn	8.50%
7	Chemed	6.93 Bn	6.89 Bn	221.47 Mn	15.37%
8	Pacs	6.81 Bn	6.64 Bn	338.46 Mn	7.66%
9	Concentra Group Holdings Parent	4.32 Bn	4.16 Bn	192.10 Mn	18.99%
10	Joint	117.66 Mn	95.51 Mn	12.70 Mn	-2.43%

Historic Data

Download Data